On May 3, 2022 Alpine Immune Sciences, Inc. (Nasdaq: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune and inflammatory diseases, reported that members of its management team will participate at the following investor conferences in May 2022 (Press release, Alpine Immune Sciences, MAY 3, 2022, View Source [SID1234613383]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

LifeSci Partners Immunology & Inflammation Symposium
Date: Tuesday, May 10, 2022
Time: 3:00 p.m. ET/12:00 p.m. PT
Event: Fireside Chat

BofA Securities Healthcare Conference 2022
Date: Wednesday, May 11, 2022
Time: 7:15 p.m. ET/4:15 p.m. PT
Event: Corporate Presentation

Webcasts of the LifeSci Partners fireside chat and BofA corporate presentation will be available online in the investor relations section of the company’s website at View Source A replay of the fireside chats will be available on the company website for 90 days following the webcast.